Table 2.
Patient and tumor characteristics.
| All (N = 2094) | Group 1: TME within 6 weeks (N = 300) | Group 2: TME between 7–12 weeks (N = 1598) | Group 3: TME ≥13 weeks (N = 196) | P value | ||
|---|---|---|---|---|---|---|
| Age, median (range) | ||||||
| 65 (23–89) | 64 (23–88) | 65 (25–89) | 67 (32–83) | <0.01a | ||
| Gender, N (%) | ||||||
| Male | 1328 (63%) | 179 (60%) | 1025 (64%) | 124 (62%) | 0.29b | |
| Female | 766 (37%) | 121 (40%) | 573 (36%) | 72 (36%) | ||
| T stage, N (%) | ||||||
| T2 | 95 (5%) | 13 (4%) | 71 (4%) | 11 (5%) | <0.01b | |
| T3 | 1747 (83%) | 220 (73%) | 1369 (85%) | 158 (80%) | ||
| T4 | 252 (12%) | 67 (22) | 158 (9%) | 27 (13%) | ||
| N stage, N (%) | ||||||
| N0 | 578 (28%) | 110 (36%) | 415 (25%) | 53 (27%) | <0.01b | |
| N1 | 1122 (53%) | 133 (44%) | 874 (54%) | 115 (58%) | ||
| N2 | 394 (19%) | 57 (19%) | 309 (19%) | 28 (14%) | ||
| Clinical stage, N (%) | ||||||
| II | 578 (28%) | 110 (36%) | 415 (25%) | 53 (27%) | <0.01b | |
| III | 1516 (72%) | 190 (63%) | 1183 (74%) | 143 (72%) |
Descriptive analysis of whole study population. p value tests the heterogeneity between study groups.
a
Mann-Whitney test.
b
Pearson’s Chi square test.